24 Jul, EOD - Indian

SENSEX 80148.88 (-0.35)

Nifty 50 24413.5 (-0.27)

Nifty Bank 51317 (-0.89)

Nifty IT 40115.05 (0.18)

Nifty Midcap 100 56872.75 (1.04)

Nifty Next 50 71844.65 (0.30)

Nifty Pharma 20908.5 (0.74)

Nifty Smallcap 100 18723.5 (1.76)

24 Jul, EOD - Global

NIKKEI 225 39154.85 (-1.11)

HANG SENG 17311.05 (-0.91)

DOW JONES 39853.87 (-1.25)

S&P 5427.13 (-2.31)

Login/Signup

Hot Pursuit News

You are Here : Home > News > Hot Pursuit News >

(27 Jun 2024, 11:05)

Dr Reddy’s Lab jumps after arm inks pact to acquire Nicotinell brand

Dr Reddy’s Laboratories added 2.27% to Rs 6,205.95 after the firm’s wholly owned subsidiary, Dr. Reddy's Laboratories SA has entered into a definitive agreement with Haleon plc and its associate companies to acquire Nicotinell and related brands.

Dr. Reddy’s Laboratories SA will acquire all of the quotas of Northstar Switzerland SARL (Northstar Switzerland), a Haleon group company. It will also aquire Haleon’s global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy (NRT) category outside of the United States.

The intellectual property, business contracts, dossiers and other assets related to the portfolio being acquired will reside in Northstar Switzerland and/or its fully owned step-down subsidiaries North Star OpCo and North Star Sweden AB to be incorporated in England and Wales and Sweden, respectively.

The acquisition will enable the company to gain access to a global OTC anchor brand and is seen as a potential vehicle to build the company’s global consumer healthcare OTC business.

Dr. Re...

More News
More Company News View Company Information